The Effect of Endothelial Progenitor Cells on Angiotensin II–induced Proliferation of Cultured Rat Vascular Smooth Muscle Cells
Authors:
- Li FangLFLi Fang
- Mei-Fang ChenMCMei-Fang Chen
- Zhi-Lin XiaoZXZhi-Lin Xiao
- Guo-Long YuGYGuo-Long Yu
- Xiao-Bin ChenXCXiao-Bin Chen
- Xiu-Mei XieXXXiu-Mei Xie
- 1 December 2011
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 58 (6) , 617-625
Abstract
Previous studies have demonstrated that endothelial progenitor cells (EPCs) could delay the progress of vascular remodeling in blood vessel–proliferating diseases. The proliferation of vascular smooth muscle cells (VSMCs) is a pivotal factor in cardiovascular diseases. In this study, we investigated whether EPCs could inhibit the Angiotensin II (Ang II)–induced proliferation of VSMCs. The effect of early EPC-conditioned medium (E-EPC-CM), late EPCs-CM (L-EPC-CM), and HUVEC-CM on Ang II–induced proliferation of VSMCs was assessed by BrdU incorporation, total protein content, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, and flow cytometry. Reverse transcriptase–polymerase chain reaction and Western blot were performed to analyze the effect of different CMs on Ang II–induced phosphorylations of ERK, JNK, p38, and NF-κB subunit p65 and the expressions of c-myc and c-fos. E-EPC-CM, L-EPC-CM, and HUVEC-CM significantly inhibited the Ang II–induced DNA synthesis, total protein expression, cell survival, and cell cycle progress of VSMCs. Furthermore, E-EPC-CM significantly inhibited the Ang II–induced phosphorylation of ERK, JNK, p38, and p65 (nuclear translocation of p65) and the expressions of c-myc and c-fos. Taken together, these data suggested that EPCs may delay the progress of vascular remodeling in blood vessel–proliferating diseases by inhibiting Ang II–induced proliferation of VSMCs through inactivating MAPKs and NF-κB signaling pathways and by reducing the expressions of c-myc and c-fos.Keywords
This publication has 32 references indexed in Scilit:
- Angiotensin II-Induced Migration of Vascular Smooth Muscle Cells Is Mediated by p38 Mitogen-Activated Protein Kinase-Activated c-Src through Spleen Tyrosine Kinase and Epidermal Growth Factor Receptor TransactivationThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Molecular Basis of Restenosis and Novel Issues of Drug-Eluting StentsCirculation Journal, 2009
- Preventing restenosis after angioplasty: a multistage approachClinical Science, 2008
- Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular DiseasesHypertension, 2005
- Transplantation of Circulating Endothelial Progenitor Cells Restores Endothelial Function of Denuded Rabbit Carotid ArteriesStroke, 2004
- Endothelial Progenitor CellsCirculation Research, 2004
- Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic GraftsCirculation, 2003
- Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery DiseaseCirculation Research, 2001
- Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997